APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mono Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Mono Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025185 pages

Choose your research edition.

Industry ResearchMono Vaccine Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Mono Vaccine Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Mono Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mono Vaccine Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Mono Vaccine Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Mono Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Mono Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Mono Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mono Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Mono Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Mono Vaccine include GSK, Merck, Pfizer, Serum Institute of India, Sanofi Pasteur MSD, Sanofi Pasteur, CNBG and Biokangtai, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Mono Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mono Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mono Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Mono Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Mono Vaccine Segment by Company

GSK

Merck

Pfizer

Serum Institute of India

Sanofi Pasteur MSD

Sanofi Pasteur

CNBG

Biokangtai

Mono Vaccine Segment by Type

Hepatitis Vaccine

Yellow Fever Vaccine

Cholera Vaccine

Meningococcal Vaccine

Japanese Encephalitis Vaccine

Other

Mono Vaccine Segment by Application

Adults

Children

Mono Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mono Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mono Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mono Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Mono Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Mono Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Mono Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Mono Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Mono Vaccine Industry Trends Table 2. Mono Vaccine Industry Drivers Table 3. Mono Vaccine Industry Opportunities and Challenges Table 4. Mono Vaccine Industry Restraints Table 5. Global Mono Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Mono Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Mono Vaccine Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Mono Vaccine Sales Market Share by Manufacturers Table 9. Global Mono Vaccine Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Mono Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Mono Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Mono Vaccine Manufacturers, Product Type & Application Table 13. Global Mono Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Mono Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Hepatitis Vaccine Table 17. Major Manufacturers of Yellow Fever Vaccine Table 18. Major Manufacturers of Cholera Vaccine Table 19. Major Manufacturers of Meningococcal Vaccine Table 20. Major Manufacturers of Japanese Encephalitis Vaccine Table 21. Major Manufacturers of Other Table 22. Global Mono Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global Mono Vaccine Sales by Type (2021-2026) & (k units) Table 24. Global Mono Vaccine Sales by Type (2027-2032) & (k units) Table 25. Global Mono Vaccine Sales Market Share by Type (2021-2026) Table 26. Global Mono Vaccine Sales Market Share by Type (2027-2032) Table 27. Global Mono Vaccine Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 28. Global Mono Vaccine Revenue by Type (2021-2026) & (k units) Table 29. Global Mono Vaccine Revenue by Type (2027-2032) & (k units) Table 30. Global Mono Vaccine Revenue Market Share by Type (2021-2026) Table 31. Global Mono Vaccine Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Adults Table 33. Major Manufacturers of Children Table 34. Global Mono Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Mono Vaccine Sales by Application (2021-2026) & (k units) Table 36. Global Mono Vaccine Sales by Application (2027-2032) & (k units) Table 37. Global Mono Vaccine Sales Market Share by Application (2021-2026) Table 38. Global Mono Vaccine Sales Market Share by Application (2027-2032) Table 39. Global Mono Vaccine Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 40. Global Mono Vaccine Revenue by Application (2021-2026) & (k units) Table 41. Global Mono Vaccine Revenue by Application (2027-2032) & (k units) Table 42. Global Mono Vaccine Revenue Market Share by Application (2021-2026) Table 43. Global Mono Vaccine Revenue Market Share by Application (2027-2032) Table 44. Global Mono Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Mono Vaccine Sales by Region (2021-2026) & (k units) Table 46. Global Mono Vaccine Sales Market Share by Region (2021-2026) Table 47. Global Mono Vaccine Sales Forecasted by Region (2027-2032) & (k units) Table 48. Global Mono Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Mono Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. North America Mono Vaccine Sales by Country (2021-2026) & (k units) Table 51. North America Mono Vaccine Sales by Country (2027-2032) & (k units) Table 52. Europe Mono Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Europe Mono Vaccine Sales by Country (2021-2026) & (k units) Table 54. Europe Mono Vaccine Sales by Country (2027-2032) & (k units) Table 55. Asia Pacific Mono Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Asia Pacific Mono Vaccine Sales by Country (2021-2026) & (k units) Table 57. Asia Pacific Mono Vaccine Sales by Country (2027-2032) & (k units) Table 58. South America, Middle East and Africa Mono Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. South America, Middle East and Africa Mono Vaccine Sales by Country (2021-2026) & (k units) Table 60. South America, Middle East and Africa Mono Vaccine Sales by Country (2027-2032) & (k units) Table 61. Global Mono Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Mono Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Mono Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Mono Vaccine Revenue Market Share by Region (2021-2026) Table 65. Global Mono Vaccine Revenue Market Share by Region (2027-2032) Table 66. GSK Company Information Table 67. GSK Business Overview Table 68. GSK Mono Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. GSK Mono Vaccine Product Portfolio Table 70. GSK Recent Development Table 71. Merck Company Information Table 72. Merck Business Overview Table 73. Merck Mono Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Merck Mono Vaccine Product Portfolio Table 75. Merck Recent Development Table 76. Pfizer Company Information Table 77. Pfizer Business Overview Table 78. Pfizer Mono Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Pfizer Mono Vaccine Product Portfolio Table 80. Pfizer Recent Development Table 81. Serum Institute of India Company Information Table 82. Serum Institute of India Business Overview Table 83. Serum Institute of India Mono Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Serum Institute of India Mono Vaccine Product Portfolio Table 85. Serum Institute of India Recent Development Table 86. Sanofi Pasteur MSD Company Information Table 87. Sanofi Pasteur MSD Business Overview Table 88. Sanofi Pasteur MSD Mono Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Sanofi Pasteur MSD Mono Vaccine Product Portfolio Table 90. Sanofi Pasteur MSD Recent Development Table 91. Sanofi Pasteur Company Information Table 92. Sanofi Pasteur Business Overview Table 93. Sanofi Pasteur Mono Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Sanofi Pasteur Mono Vaccine Product Portfolio Table 95. Sanofi Pasteur Recent Development Table 96. CNBG Company Information Table 97. CNBG Business Overview Table 98. CNBG Mono Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. CNBG Mono Vaccine Product Portfolio Table 100. CNBG Recent Development Table 101. Biokangtai Company Information Table 102. Biokangtai Business Overview Table 103. Biokangtai Mono Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Biokangtai Mono Vaccine Product Portfolio Table 105. Biokangtai Recent Development Table 106. Key Raw Materials Table 107. Raw Materials Key Suppliers Table 108. Mono Vaccine Distributors List Table 109. Mono Vaccine Customers List Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. Mono Vaccine Product Image Figure 2. Global Mono Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mono Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Mono Vaccine Sales (2021-2032) & (k units) Figure 5. Global Mono Vaccine Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Mono Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Hepatitis Vaccine Image Figure 9. Yellow Fever Vaccine Image Figure 10. Cholera Vaccine Image Figure 11. Meningococcal Vaccine Image Figure 12. Japanese Encephalitis Vaccine Image Figure 13. Other Image Figure 14. Global Mono Vaccine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Mono Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Mono Vaccine Sales Market Share by Type (2021-2032) Figure 17. Global Mono Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 18. Global Mono Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Mono Vaccine Revenue Market Share by Type (2021-2032) Figure 20. Adults Image Figure 21. Children Image Figure 22. Global Mono Vaccine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Mono Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Mono Vaccine Sales Market Share by Application (2021-2032) Figure 25. Global Mono Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global Mono Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Mono Vaccine Revenue Market Share by Application (2021-2032) Figure 28. North America Mono Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 29. North America Mono Vaccine Sales Market Share by Country (2021-2032) Figure 30. U.S. Mono Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 31. Canada Mono Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 32. Mexico Mono Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Mono Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Mono Vaccine Sales Market Share by Country (2021-2032) Figure 35. Germany Mono Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 36. France Mono Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 37. U.K. Mono Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 38. Italy Mono Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 39. Netherlands Mono Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Mono Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Mono Vaccine Sales Market Share by Country (2021-2032) Figure 42. China Mono Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 43. Japan Mono Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 44. South Korea Mono Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 45. Southeast Asia Mono Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 46. India Mono Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 47. Australia Mono Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Mono Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Mono Vaccine Sales Market Share by Country (2021-2032) Figure 50. Brazil Mono Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 51. South Africa Mono Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 52. Saudi Arabia Mono Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 53. Turkey Mono Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 54. Argentina Mono Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 55. UAE Mono Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 56. Egypt Mono Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 57. Chile Mono Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 58. Global Mono Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Mono Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Mono Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. North America Mono Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Mono Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. Europe Mono Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Mono Vaccine Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Mono Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Mono Vaccine Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Mono Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Mono Vaccine Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Mono Vaccine Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Hepatitis Vaccine
  • Yellow Fever Vaccine
  • Cholera Vaccine
  • Meningococcal Vaccine
  • Japanese Encephalitis Vaccine
  • Other
Applications
  • Adults
  • Children
Companies covered
  • GSK
  • Merck
  • Pfizer
  • Serum Institute of India
  • Sanofi Pasteur MSD
  • Sanofi Pasteur
  • CNBG
  • Biokangtai

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Mono Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Mono Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Mono Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Mono Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Mono Vaccine Market Dynamics
  1. 2.1 Mono Vaccine Industry Trends
  2. 2.2 Mono Vaccine Industry Drivers
  3. 2.3 Mono Vaccine Industry Opportunities and Challenges
  4. 2.4 Mono Vaccine Industry Restraints
3 Mono Vaccine Market by Manufacturers
  1. 3.1 Global Mono Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Mono Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Mono Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Mono Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Mono Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Mono Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Mono Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Mono Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Mono Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Mono Vaccine Tier 1, Tier 2, and Tier 3
4 Mono Vaccine Market by Type
  1. 4.1 Mono Vaccine Type Introduction
  2. 4.1.1 Hepatitis Vaccine
  3. 4.1.2 Yellow Fever Vaccine
  4. 4.1.3 Cholera Vaccine
  5. 4.1.4 Meningococcal Vaccine
  6. 4.1.5 Japanese Encephalitis Vaccine
  7. 4.1.6 Other
  8. 4.2 Global Mono Vaccine Sales by Type
  9. 4.2.1 Global Mono Vaccine Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Mono Vaccine Sales by Type (2021-2032)
  11. 4.2.3 Global Mono Vaccine Sales Market Share by Type (2021-2032)
  12. 4.3 Global Mono Vaccine Revenue by Type
  13. 4.3.1 Global Mono Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Mono Vaccine Revenue by Type (2021-2032)
  15. 4.3.3 Global Mono Vaccine Revenue Market Share by Type (2021-2032)
5 Mono Vaccine Market by Application
  1. 5.1 Mono Vaccine Application Introduction
  2. 5.1.1 Adults
  3. 5.1.2 Children
  4. 5.2 Global Mono Vaccine Sales by Application
  5. 5.2.1 Global Mono Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Mono Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global Mono Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Mono Vaccine Revenue by Application
  9. 5.3.1 Global Mono Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Mono Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global Mono Vaccine Revenue Market Share by Application (2021-2032)
6 Global Mono Vaccine Sales by Region
  1. 6.1 Global Mono Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Mono Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Mono Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Mono Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Mono Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Mono Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Mono Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Mono Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Mono Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Mono Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Mono Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Mono Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Mono Vaccine Revenue by Region
  1. 7.1 Global Mono Vaccine Revenue by Region
  2. 7.1.1 Global Mono Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Mono Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Mono Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Mono Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Mono Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Mono Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Mono Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Mono Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Mono Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Mono Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Mono Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Mono Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 GSK
  2. 8.1.1 GSK Company Information
  3. 8.1.2 GSK Business Overview
  4. 8.1.3 GSK Mono Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 GSK Mono Vaccine Product Portfolio
  6. 8.1.5 GSK Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Mono Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck Mono Vaccine Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Mono Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Mono Vaccine Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 Serum Institute of India
  20. 8.4.1 Serum Institute of India Company Information
  21. 8.4.2 Serum Institute of India Business Overview
  22. 8.4.3 Serum Institute of India Mono Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Serum Institute of India Mono Vaccine Product Portfolio
  24. 8.4.5 Serum Institute of India Recent Developments
  25. 8.5 Sanofi Pasteur MSD
  26. 8.5.1 Sanofi Pasteur MSD Company Information
  27. 8.5.2 Sanofi Pasteur MSD Business Overview
  28. 8.5.3 Sanofi Pasteur MSD Mono Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sanofi Pasteur MSD Mono Vaccine Product Portfolio
  30. 8.5.5 Sanofi Pasteur MSD Recent Developments
  31. 8.6 Sanofi Pasteur
  32. 8.6.1 Sanofi Pasteur Company Information
  33. 8.6.2 Sanofi Pasteur Business Overview
  34. 8.6.3 Sanofi Pasteur Mono Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sanofi Pasteur Mono Vaccine Product Portfolio
  36. 8.6.5 Sanofi Pasteur Recent Developments
  37. 8.7 CNBG
  38. 8.7.1 CNBG Company Information
  39. 8.7.2 CNBG Business Overview
  40. 8.7.3 CNBG Mono Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 CNBG Mono Vaccine Product Portfolio
  42. 8.7.5 CNBG Recent Developments
  43. 8.8 Biokangtai
  44. 8.8.1 Biokangtai Company Information
  45. 8.8.2 Biokangtai Business Overview
  46. 8.8.3 Biokangtai Mono Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Biokangtai Mono Vaccine Product Portfolio
  48. 8.8.5 Biokangtai Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Mono Vaccine Value Chain Analysis
  2. 9.1.1 Mono Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Mono Vaccine Production Mode & Process
  6. 9.2 Mono Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Mono Vaccine Distributors
  9. 9.2.3 Mono Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst